Celia started her career working in a NHS substance misuse clinic in London as an assistant psychologist which sparked a lifelong interest in treating addiction. She completed her PhD in Clinical Psychology at University College London in 2006, researching the acute and chronic effects of ketamine during this time. She remained at UCL, with brief stints at Uni of Melbourne and Yale and awarded a Chair as Professor of Psychopharmacology in 2015. She has held a number of grants from the UK government, particularly the Medical Research Council, along with charities such as the Wellcome Trust. The focus of Celia’s research has been on both the potential for therapeutic and harmful use of a range of controlled substances including MDMA, ketamine, ayahuasca and LSD. She is currently running a Department for Health (UK) funded Phase 3 clinical trial of ketamine assisted therapy for alochol use disorder, and lives by the ocean in Cornwall, UK with her partner, two children and dog Momo. |